CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
Page 1 of 2 · 31 filings